This website uses cookies to enhance the user experience.
||
4

4 LB INVEST AS996 626 083

Limited company
Sund 8384 SUND I LOFOTEN, Norge

4 LB INVEST AS

Operating
Investering i aksjer og andeler i andre selskaper.
Investering i aksjer og deltakelse i andre selskaper.

Organization

Chairman of the board
Years since formation
15 years
since Feb 26, 2011
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,500
1 share class
Total number of shareholders
4
persons

Financials

Annual total result 2025
1,161,359
NOK
Total equity 2025
-7,279,056
NOK
Last update: Apr 28, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
80.93 %
directly

Board

NameRoleShares
Chairman
80.93 %
directly
Alternate Member
11.47 %
directly

Others

NameRoleShares
L
LOFOTREVISJON AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
80.93 %
directly
Alternate Member
11.47 %
directly
-
3.8 %
directly
-
3.8 %
directly
Last update: Feb 14, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1,214
80.93 %
Ordinary shares
172
11.47 %
Ordinary shares
57
3.8 %
Ordinary shares
57
3.8 %

Shares owned by the 4 LB INVEST AS

NameShare classTotal number of sharesShare
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
8,533
0.27 %
A
AMICOAT AS
NO0010799679
90,591
0.24 %
L
LYTIX BIOPHARMA ASA
NO0010405780
160,040
0.23 %
P
PHARMA HOLDINGS AS
NO0010797350
1,808
0.15 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
1,161,359
-259,032
-483,866
-2,214,252
-8,175,652
Total assets
1,722,621
539,637
777,794
1,241,910
3,437,537
Total liabilities
9,001,677
8,980,052
8,959,177
8,939,427
8,920,802
Total equity
-7,279,056
-8,440,415
-8,181,383
-7,697,517
-5,483,265

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
21,625
20,875
19,750
18,625
17,625
Operating result
-21,625
-20,875
-19,750
-18,625
-17,625
Financial income/costs
1,182,984
-238,157
-464,116
-2,195,627
-8,158,027
Profit before tax
1,161,359
-259,032
-483,866
-2,214,252
-8,175,652
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
1,161,359
-259,032
-483,866
-2,214,252
-8,175,652

Balance overview

Year20252024202320222021
Total fixed assets
1,722,621
539,637
777,794
1,241,910
3,437,537
Total current assets
0
0
0
0
0
Total assets
1,722,621
539,637
777,794
1,241,910
3,437,537
Short term debt
74,209
74,209
74,209
92,834
91,834
Long term debt
0
8,905,844
8,884,969
8,846,594
8,828,968
Total liabilities
9,001,677
8,980,052
8,959,177
8,939,427
8,920,802
Contributed capital
2,782,366
2,782,366
2,782,366
2,782,366
2,782,366
Retained earnings
-10,061,422
-11,222,781
-10,963,749
-10,479,883
-8,265,631
Total equity
-7,279,056
-8,440,415
-8,181,383
-7,697,517
-5,483,265
Total equity and liabilities
1,722,621
539,637
777,794
1,241,910
3,437,537

Classification

21st company classification
BETA
Small company
Type of organization
Limited company